A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.

Researchers found that an AI tool called Unfold AI, developed by researchers at UCLA and Avenda Health, accurately estimates prostate tumor volume and helps identify patients with a higher chance of successful treatment.

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by identifying not just which patient populations may benefit but also how the drugs work inside cells.

The researchers have demonstrated the tool's potential by identifying a promising candidate to prevent heart failure, a leading cause of death in the United States and around the world.

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS) manage fatigue, one of the most common and debilitating symptoms of the disease.

The research, led by researcher dr. Guido Giunti and neurologists dr. Mervi Ryytty and assistant professor Johanna Krüger from the University of Oulu and Oulu University Hospital in Finland, evaluated the feasibility, usability, and impact of More Stamina over a 60-day period.

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet, solving puzzles and increasing social interactions.

Multidomain interventions, including games and exercises delivered through smartphone-based apps, have also proven effective in slowing cognitive decline in this population.

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results in tests with patients at high risk for heart attack or stroke.

Over the course of eight weeks, the participants’ average blood pressure readings decreased from 139/87 mmHG to a more manageable 126/83 mmHg.

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing MCI can be a long and difficult process, especially in rural areas where access to licensed neuropsychologists is limited.

To increase accessibility to cognitive assessments, a team of researchers at the University of Missouri created a portable system to efficiently measure multiple aspects of motor function.

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human. That preference was diminished, though not erased, when told AI was involved.

The study, publishing March 11 in JAMA Network Open, showed high overall satisfaction with communications written both by AI and humans, despite their preference for AI.